Compare Ares Capital Corporation (ARCC) vs Atomera Incorporated (ATOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ares Capital Corporation vs Atomera Incorporated — how do they compare? Ares Capital Corporation trades at $18.77 (market cap $13.48B), while Atomera Incorporated trades at $6.31 (market cap $256.50M). The key difference: Ares Capital Corporation is far larger — about 52.6× Atomera Incorporated's market cap, and Ares Capital Corporation pays a 10.22% dividend while Atomera Incorporated pays none. Which is the better fit depends on your goals.
| ARCC | ATOM | |
|---|---|---|
Market Cap | $13.48B | $256.50M |
Sector | Financials | Technology |
52-Week High | $23.25 | $12.11 |
52-Week Low | $17.45 | $1.99 |
Dividend Yield | 10.22% | — |
Enterprise Value | — | $216.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ares Capital (ARCC) trades at $18.78, up 2.01% on the day, with a bearish technical signal but strong analyst support. The stock shows a P/E of 11.52 and P/B of 0.96, trading below the consensus price target of $20.58. Recent earnings have missed expectations, with Q2 2026 results pending, while revenue declined to $1.51B in 2025 from $1.7B in 2024. A dividend of $0.48 is scheduled for payment on June 30, 2026, supporting income appeal amid mixed sentiment.
ARCC presents a value opportunity with a high dividend yield and undervaluation relative to analyst targets, but faces headwinds from earnings misses and a bearish technical outlook. Risks include revenue volatility and competitive pressures in the BDC space, though institutional buy ratings suggest confidence in recovery potential. Investors should weigh income stability against growth challenges.
ATOM trades at $6.63, down 2.93% with bearish technical signals. The company shows severe financial strain with negative gross profit margin of -520.83% and net income margin of -29,219.44% for 2025. Recent earnings misses and negative cash flow highlight operational challenges, though analyst consensus remains 100% buy rating based on technology licensing potential in semiconductor materials.
Outlook remains speculative with significant execution risk. The company's GaN-on-Silicon technology partnerships with Synopsys offer potential upside, but current financial metrics and consistent losses warrant caution. Investment opportunity exists only for risk-tolerant investors betting on technology adoption breakthroughs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →About Atomera Incorporated
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →
